1. Home
  2. MRSN vs ZCMD Comparison

MRSN vs ZCMD Comparison

Compare MRSN & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • ZCMD
  • Stock Information
  • Founded
  • MRSN 2001
  • ZCMD 2012
  • Country
  • MRSN United States
  • ZCMD China
  • Employees
  • MRSN N/A
  • ZCMD N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • ZCMD Other Consumer Services
  • Sector
  • MRSN Health Care
  • ZCMD Real Estate
  • Exchange
  • MRSN Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • MRSN 36.4M
  • ZCMD 30.3M
  • IPO Year
  • MRSN 2017
  • ZCMD 2020
  • Fundamental
  • Price
  • MRSN $0.35
  • ZCMD $1.19
  • Analyst Decision
  • MRSN Buy
  • ZCMD
  • Analyst Count
  • MRSN 3
  • ZCMD 0
  • Target Price
  • MRSN $4.00
  • ZCMD N/A
  • AVG Volume (30 Days)
  • MRSN 3.1M
  • ZCMD 3.8K
  • Earning Date
  • MRSN 05-08-2025
  • ZCMD 01-01-0001
  • Dividend Yield
  • MRSN N/A
  • ZCMD N/A
  • EPS Growth
  • MRSN N/A
  • ZCMD N/A
  • EPS
  • MRSN N/A
  • ZCMD N/A
  • Revenue
  • MRSN $40,497,000.00
  • ZCMD $17,406,104.00
  • Revenue This Year
  • MRSN N/A
  • ZCMD N/A
  • Revenue Next Year
  • MRSN N/A
  • ZCMD N/A
  • P/E Ratio
  • MRSN N/A
  • ZCMD N/A
  • Revenue Growth
  • MRSN 9.88
  • ZCMD 1.01
  • 52 Week Low
  • MRSN $0.26
  • ZCMD $1.00
  • 52 Week High
  • MRSN $3.83
  • ZCMD $2.97
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 44.90
  • ZCMD 39.96
  • Support Level
  • MRSN $0.31
  • ZCMD $1.20
  • Resistance Level
  • MRSN $0.40
  • ZCMD $1.46
  • Average True Range (ATR)
  • MRSN 0.05
  • ZCMD 0.08
  • MACD
  • MRSN 0.01
  • ZCMD -0.01
  • Stochastic Oscillator
  • MRSN 68.09
  • ZCMD 25.00

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

Share on Social Networks: